IN2009KN03959A - - Google Patents

Download PDF

Info

Publication number
IN2009KN03959A
IN2009KN03959A IN3959KON2009A IN2009KN03959A IN 2009KN03959 A IN2009KN03959 A IN 2009KN03959A IN 3959KON2009 A IN3959KON2009 A IN 3959KON2009A IN 2009KN03959 A IN2009KN03959 A IN 2009KN03959A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
relates
patient
administering
treating
Prior art date
Application number
Other languages
English (en)
Inventor
Iwao Ojima
Seung-Yub Lee
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of IN2009KN03959A publication Critical patent/IN2009KN03959A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN3959KON2009 2007-04-20 2008-04-21 IN2009KN03959A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91298007P 2007-04-20 2007-04-20
PCT/US2008/005084 WO2008130669A1 (en) 2007-04-20 2008-04-21 Benzimidazoles and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
IN2009KN03959A true IN2009KN03959A (ru) 2015-08-28

Family

ID=39875833

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3959KON2009 IN2009KN03959A (ru) 2007-04-20 2008-04-21

Country Status (17)

Country Link
US (1) US8232410B2 (ru)
EP (1) EP2154966B1 (ru)
JP (1) JP5400032B2 (ru)
CN (1) CN101677553A (ru)
AU (1) AU2008242488B2 (ru)
BR (1) BRPI0810244A2 (ru)
CA (1) CA2684594C (ru)
DK (1) DK2154966T3 (ru)
EA (1) EA016726B1 (ru)
ES (1) ES2434693T3 (ru)
HR (1) HRP20131103T1 (ru)
IN (1) IN2009KN03959A (ru)
MX (1) MX2009011281A (ru)
PL (1) PL2154966T3 (ru)
PT (1) PT2154966E (ru)
SI (1) SI2154966T1 (ru)
WO (1) WO2008130669A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8232310B2 (en) 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
US8039502B2 (en) 2007-07-24 2011-10-18 The Ohio State University Research Foundation Anti-infective agents against intracellular pathogens
US20120108823A1 (en) * 2009-04-22 2012-05-03 The Ohio State University Research Foundation Anti-francisella agents
EA022007B1 (ru) 2009-09-11 2015-10-30 Пробиодруг Аг Гетероциклические производные в качестве ингибиторов глутаминилциклазы
WO2013116823A1 (en) * 2012-02-02 2013-08-08 The Research Foundation Of State University Of New York Benzimidazoles and uses thereof
WO2013142326A1 (en) * 2012-03-23 2013-09-26 The Research Foundation Of State University Of New York 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis
NZ700612A (en) 2012-04-12 2016-09-30 Univ Georgetown Methods and compositions for treating ewings sarcoma family of tumors
CN103333170B (zh) * 2013-06-14 2016-08-10 清华大学 苯并咪唑类化合物及其用途
WO2015061229A1 (en) 2013-10-24 2015-04-30 Georgetown University Methods and compositions for treating cancer
WO2015077276A1 (en) 2013-11-22 2015-05-28 The Research Foundation For The State University Of New York Benzimidazoles and their use in the treatment of tuberculosis
WO2015138611A2 (en) 2014-03-11 2015-09-17 Colorado State University Research Foundation Methods for improved in vitro-in vivo efficacy determination
JP2017518339A (ja) * 2014-06-20 2017-07-06 インスティチュート パスツール コリア 抗感染化合物
CA2961781C (en) 2014-10-09 2023-10-03 Oncternal Therapeutics, Inc. Indolinone compounds and uses thereof
US9822122B2 (en) 2016-03-31 2017-11-21 Oncternal Therapeutics, Inc. Indoline analogs and uses thereof
KR102282794B1 (ko) 2016-07-29 2021-07-27 온크터널 테라퓨틱스, 인코포레이티드. 인돌리논 화합물의 용도
CN111303092B (zh) * 2020-04-07 2021-05-25 山东昌邑灶户盐化有限公司 2,4-二硝基-6-氯苯胺衍生物、合成方法及其应用
EP4367112A1 (en) 2021-07-09 2024-05-15 Plexium, Inc. Aryl compounds and pharmaceutical compositions that modulate ikzf2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61170732A (ja) * 1985-01-25 1986-08-01 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
CA2582356A1 (en) * 2004-09-30 2006-04-13 Janssen Pharmaceutica N.V. Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
CN101438288A (zh) * 2006-03-15 2009-05-20 Csir公司 谷氨酰胺合成酶的磷酰基转移酶活性的调节

Also Published As

Publication number Publication date
JP5400032B2 (ja) 2014-01-29
EA016726B1 (ru) 2012-07-30
PL2154966T3 (pl) 2014-03-31
PT2154966E (pt) 2013-11-13
AU2008242488A1 (en) 2008-10-30
EP2154966A4 (en) 2010-12-15
DK2154966T3 (da) 2013-11-18
EA200901423A1 (ru) 2010-06-30
ES2434693T3 (es) 2013-12-17
US8232410B2 (en) 2012-07-31
SI2154966T1 (sl) 2014-02-28
AU2008242488B2 (en) 2014-10-30
CN101677553A (zh) 2010-03-24
JP2010524947A (ja) 2010-07-22
MX2009011281A (es) 2010-03-08
HRP20131103T1 (hr) 2013-12-20
WO2008130669A1 (en) 2008-10-30
US20100256203A1 (en) 2010-10-07
CA2684594C (en) 2015-10-06
BRPI0810244A2 (pt) 2014-09-30
EP2154966A1 (en) 2010-02-24
CA2684594A1 (en) 2008-10-30
EP2154966B1 (en) 2013-08-21

Similar Documents

Publication Publication Date Title
IN2009KN03959A (ru)
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
MX2014002171A (es) Tratamientos de combinacion para hepatitis c.
CY1116989T1 (el) C-28 αμινες c-3 τροποποιημενων παραγωγων βετουλινικου οξεος ως αναστολεις hiv ωριμανσης
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
PH12015500719A1 (en) Gdf-8-inhibitors
EA201100971A1 (ru) Производные пиримидининдола для лечения злокачественного новообразования
MX2020008616A (es) Rocio de fentanilo sublingual.
MX2010008921A (es) Derivados de oxazolidinona.
MY145795A (en) Pyrazoline compounds
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
NZ600874A (en) Fluorinated derivatives of deferiprone
CY1119118T1 (el) Θεραπευτικος παραγων για τις διαταραχες της διαθεσης
AU2009331669A8 (en) Dihydropyridone amides as P2X7 modulators
WO2011014825A3 (en) Antiangiogenic small molecules and methods of use
BR112012016783A2 (pt) "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
MX341341B (es) Derivados de benzamida y su uso como inhibidores de proteina de choque termico 90 kda (hsp90).
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
MX2012013879A (es) Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas.
PH12015500012B1 (en) Benzodioxole derivative and preparation method and use thereof
MX2009005798A (es) Recuperacion de apoplejia.
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
EA201690327A1 (ru) Терапевтические способы
BRPI0917245B8 (pt) compostos derivados de isoquinolinona e sua composição farmacêutica
CY1119483T1 (el) Θεραπευτικος παραγων για τις αγχωδεις διαταραχες